Old Web
English
Sign In
Acemap
>
Paper
>
CLINICAL CHARACTERISTICS AND OUTCOMES OF STAGE I DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB-ERA
CLINICAL CHARACTERISTICS AND OUTCOMES OF STAGE I DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB-ERA
2019
S. Bobillo
Erel Joffe
J. Lavery
Ariela Noy
Lia Palomba
David J. Straus
Anita Kumar
C. Batlevi
Steve Horwitz
A. Moskowitz
Paul A. Hamlin
Andrew D. Zelenetz
M. Matasar
G. von Keudell
David Sermer
Joachim Yahalom
Ahmet Dogan
Venkatraman E. Seshan
Anas Younes
Keywords:
Pathology
Stage I Diffuse Large B-Cell Lymphoma
Rituximab
Internal medicine
Oncology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]